MedPath

The effect of vaginal Evening Primrose Oil capsule versus placebo on cervical ripening and delivery outcomes in nulliparous wome

Phase 2
Conditions
Delivery outcomes.
Encounter for supervision of other normal pregnancy, third trimester
Z34.83
Registration Number
IRCT20120215009014N231
Lead Sponsor
Hamedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
50
Inclusion Criteria

Age of 18 to 45 years;
Nulliparous;
Cephalic presentation of embryo and alive with normal patterns of embryonic heart rate;
Embryonic weight of 2500 to 3500 g;
Gestational age of 38 to 39 weeks;
Bishop score of 4 or lower

Exclusion Criteria

Sensitivity of herbal medications;
Amniotic fluid disorder;
Preeclampsia;
Diabetes;
Placenta aberration;
Placenta Previa;
Indication of cesarean

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cervical ripening. Timepoint: During delivery. Method of measurement: With physical examination.;Neonate Apgar score. Timepoint: In the first and fifth minutes after delivery. Method of measurement: With physical examination.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath